TITLE:
Constitutively Active Soluble Form of Erythropoietin Receptor Suppresses Growth and Angiogenesis of Xenografts of Transfected Cancer Cell Lines
AUTHORS:
Yoshiko Yasuda, Yasuhiro Maeda, Satoshi Hara, Motoyoshi Tanaka, Eiji Koike, Yoh Watanabe, Seiji Masuda, Harufumi Yamasaki, Katsumi Okumoto, Hiroyoshi Konishi, Yoshitaka Horiuchi, Hiroshi Hoshiai
KEYWORDS:
Erythropoietin, Erythropoietin Receptor, Soluble Form of Erythropoietin Receptor, ERK1/2/MAPK, Adrenoreceptor, Acetylcholine Receptor, Immunohistochemistry, Western Blot, Real-Time RT-PCR, Nude Mice
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.2 No.1,
March
8,
2011
ABSTRACT: We examined the effect of blocking the erythropoietin (Epo) signaling using an anti-Epo antibody, soluble form of Epo receptor (sEpoR) capable of binding to Epo or EpoR antagonist, and proved to be effective against xenografts of female reproductive organ malignancies and of cancer cell lines in nude mice. We transfected seven cancer cell lines of various origins to express constitutively active sEpoR, and examined their tumorigenesis in nude mice. Suppression of the tumor growth, decrease in viable and proliferating cells and reduction of vascular density were seen individually in all xenografts of transfected cell lines compared with the controls. Quantitative RT-PCR analyses showed that expression levels of Epo, EpoR, ?1A-adrenaline receptor (?1A-ADR) and muscalinic acetylcholine receptor subunit 3 mRNAs (m3-AchR) were higher in the majority of the wild-type xenografts than in the corresponding cell lines except for A549. In some of the transfected xenografts, EpoR, ?1A-ADR and m3-AchR mRNAs were down-regulated. Western blot analyses revealed that the constitutively activated ERK1/2MAPK was discernible in the majority of non-transfected cell lines and was reduced in the transfected cell lines. However, it was regained after exposure to acetylcholine and/or noradrenaline. These findings suggest that constitutively active sEpoR can effectively destroy the xenografts but signals from the autonomic neurotransmitters of the host produced under stress may interfere with this antitumor activity.